Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Godrej Industries Limited (GODREJIND.NS)
Mumbai, IN
Godrej Industries Limited, a diversified Indian conglomerate founded in Mumbai in 1897, conducts extensive operations both domestically and internationally through its numerous subsidiaries. The company maintains a significant footprint across various core sectors, including chemicals, consumer goods, real estate, agriculture, and financial services. Within its chemical division, Godrej Industries manufactures and distributes a range of vital products such as fatty alcohols, fatty acids, esters, waxes, refined glycerine, alpha olefin sulphonates, and various sodium lauryl sulphates (SLS and SLES). Its agricultural undertakings involve the production and sale of specialized compound feeds for cattle, poultry, shrimp, and fish, alongside the refining and trading of vegetable oils and vanaspati. The company also manages oil palm plantations and is active in agri-inputs and seed businesses. Its consumer offerings span hair, home, and personal care products, in addition to dairy product processing, integrated poultry farming, and cattle breeding. Beyond these, Godrej Industries is engaged in real estate development, encompassing the sale, leasing, and licensing of properties. It also provides financial and investment services, notably in housing finance, and contributes to renewable energy generation through its windmill operations. The enterprise, originally established as Godrej Soaps Limited, adopted its current name in April 2001.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.92% | +4.48% | +22.27% | +10.53% | +6.96% | +13.14% | -1.93% | +141.32% | +102.01% | +231.22% | +38,770.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
-
Revenue growth Conglomerates: +6.1%+6.0% Q1'26: +40.9% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+26.4% ★ Q1'26: +142.5% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%-56.5% Q1'26: -59.0% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+7.8% Q1'26: +13.3% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+2.0% Q1'26: +4.8% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%0.0% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×23.00× Q1'26: 11.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 2001 actual |
Mar 2009 actual |
Mar 2012 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.12B
est.
|
6.17B
est.
|
7.05B
est.
|
7.30B
est.
|
33.62B
est: 32.58B (+3.2%)
|
56.12B
est: 61.08B (-8.1%)
|
80.45B
est: 82.27B (-2.2%)
|
93.51B
est: 93.03B (+0.5%)
|
76.52B
est: 108.08B (-29.2%)
|
85.23B
est: 117.70B (-27.6%)
|
94.64B
est: 123.76B (-23.5%)
|
112.92B
est: 107.50B (+5.0%)
|
118.18B
est: 119.33B (-1.0%)
|
99.79B
est: 100.93B (-1.1%)
|
209.83B
est: 93.03B (+125.6%)
|
108.08B
108.08B – 108.08B
+16.2% YoY
|
117.70B
117.70B – 117.70B
+8.9% YoY
|
123.76B
123.76B – 123.76B
+5.2% YoY
|
107.50B
107.50B – 107.50B
-13.1% YoY
|
119.33B
119.33B – 119.33B
+11.0% YoY
|
| EBITDA |
915.67M
est.
|
777.77M
est.
|
889.94M
est.
|
921.57M
est.
|
3.28B
est: 4.11B (-20.3%)
|
4.57B
est: 7.71B (-40.7%)
|
5.98B
est: 10.38B (-42.3%)
|
6.22B
est: 7.75B (-19.7%)
|
5.97B
est: 7.54B (-20.8%)
|
8.17B
est: 6.52B (+25.3%)
|
6.64B
est: 5.91B (+12.4%)
|
11.40B
est: 13.83B (-17.6%)
|
13.16B
est: 15.90B (-17.3%)
|
9.62B
est: 13.05B (-26.3%)
|
33.71B
est: 20.40B (+65.2%)
|
23.71B
23.71B – 23.71B
+16.2% YoY
|
25.82B
25.82B – 25.82B
+8.9% YoY
|
27.15B
27.15B – 27.15B
+5.2% YoY
|
23.58B
23.58B – 23.58B
-13.1% YoY
|
26.17B
26.17B – 26.17B
+11.0% YoY
|
| EBIT |
788.10M
est.
|
669.41M
est.
|
765.96M
est.
|
793.18M
est.
|
2.81B
est: 3.54B (-20.7%)
|
3.55B
est: 6.63B (-46.4%)
|
5.28B
est: 8.93B (-40.9%)
|
5.29B
est: 4.70B (+12.6%)
|
4.80B
est: 6.81B (-29.5%)
|
6.68B
est: 3.53B (+89.1%)
|
4.89B
est: 4.33B (+12.9%)
|
9.81B
est: 11.91B (-17.6%)
|
11.18B
est: 5.19B (+115.4%)
|
7.20B
est: 11.23B (-35.9%)
|
30.06B
est: 19.25B (+56.1%)
|
22.37B
22.37B – 22.37B
+16.2% YoY
|
24.36B
24.36B – 24.36B
+8.9% YoY
|
25.61B
25.61B – 25.61B
+5.2% YoY
|
22.25B
22.25B – 22.25B
-13.1% YoY
|
24.70B
24.70B – 24.70B
+11.0% YoY
|
| Net Income |
424.94M
est.
|
239.14M
est.
|
199.28M
est.
|
457.10M
est.
|
1.11B
est: 1.95B (-42.8%)
|
2.92B
est: 4.25B (-31.3%)
|
3.26B
est: 3.48B (-6.3%)
|
4.02B
est: 3.78B (+6.4%)
|
1.61B
est: 4.63B (-65.3%)
|
2.56B
est: 1.73B (+48.0%)
|
3.38B
est: 2.08B (+62.7%)
|
5.90B
est: 6.79B (-13.2%)
|
5.54B
est: 5.71B (-3.0%)
|
3.35B
est: 11.61B (-71.2%)
|
9.81B
est: 3.00B (+227.4%)
|
3.40B
3.40B – 3.40B
+13.5% YoY
|
3.94B
3.94B – 3.94B
+15.8% YoY
|
8.99B
8.99B – 8.99B
+128.2% YoY
|
6.79B
6.79B – 6.79B
-24.5% YoY
|
7.42B
7.42B – 7.42B
+9.2% YoY
|
| SGA |
660.65M
est.
|
916.73M
est.
|
642.09M
est.
|
664.91M
est.
|
263.76M
est: 4.84B (-94.6%)
|
3.99B
est: 5.56B (-28.2%)
|
6.17B
est: 7.49B (-17.7%)
|
3.86B
est: 4.90B (-21.3%)
|
4.92B
est: 10.16B (-51.5%)
|
6.02B
est: 8.66B (-30.4%)
|
7.76B
est: 7.51B (+3.3%)
|
7.62B
est: 9.98B (-23.6%)
|
9.01B
est: 10.81B (-16.6%)
|
10.00B
est: 9.42B (+6.1%)
|
24.16B
est: 8.64B (+179.7%)
|
10.04B
10.04B – 10.04B
+16.2% YoY
|
10.93B
10.93B – 10.93B
+8.9% YoY
|
11.49B
11.49B – 11.49B
+5.2% YoY
|
9.98B
9.98B – 9.98B
-13.1% YoY
|
11.08B
11.08B – 11.08B
+11.0% YoY
|
| EPS |
1.26
est.
|
0.71
est.
|
0.59
est.
|
1.35
est.
|
3.49
est: 5.75 (-39.3%)
|
9.17
est: 12.54 (-26.9%)
|
9.73
est: 10.29 (-5.5%)
|
12.00
est: 8.90 (+34.8%)
|
4.51
est: 10.10 (-55.3%)
|
7.13
est: 11.70 (-39.1%)
|
10.00
est: 26.70 (-62.5%)
|
19.76
est: 20.17 (-2.0%)
|
11.30
est: 22.03 (-48.7%)
|
9.91
est: 34.31 (-71.1%)
|
29.14
est: 8.90 (+227.4%)
|
10.10
10.10 – 10.10
+13.5% YoY
|
11.70
11.70 – 11.70
+15.8% YoY
|
26.70
26.70 – 26.70
+128.2% YoY
|
20.17
20.17 – 20.17
-24.5% YoY
|
22.03
22.03 – 22.03
+9.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | B- | 3/5 | 1/5 | 4/5 | 3/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.01% | 14.9K | 0.07% |
| 2 | Schwab Emerging Markets Equity ETF SCHE | 0.01% | 787.0K | 0.06% |
| 3 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.00% | 27.1K | 0.40% |
| 4 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 60.7K | 0.48% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 137.0K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 6.76M | 0.06% |
| 7 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 227.7K | 0.17% |
| 8 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 227.7K | 0.17% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 86.9K | 0.10% |
| 10 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.00% | 56.3K | 0.04% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Vishal Sharma | Chief Executive Officer of GIL Chemicals & Whole-Time Director | 104M | male |
| Tanya Arvind Dubash | Chief Brand Officer & Whole-Time Director | 100M | female |
| Nadir Burjorji Godrej | MD & Chairman | 87M | male |
| Manish Shah | MD & Chief Executive Officer of Godrej Capital | — | male |
| Anupama Kamble | Company Secretary & Compliance Officer | — | female |
| Sujit Patil | Head of Corporate Communications | — | male |
| Sumit Mitra | Head of Group Human Resources & Corporate Services | — | male |
| Sudhir Sitapati | MD & Chief Executive Officer of Godrej Consumer Products | — | male |
| Clement G. Pinto | Chief Financial Officer | — | male |
| Karan Bolaria | MD & CEO of Godrej Fund Management | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GODREJIND.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
